BNTX logo

BNTX
BioNTech SE - ADR

18,969
Mkt Cap
$23.02B
Volume
1.19M
52W High
$129.27
52W Low
$81.20
PE Ratio
-36.39
BNTX Fundamentals
Price
$96.00
Prev Close
$95.74
Open
$96.35
50D MA
$102.68
Beta
0.83
Avg. Volume
1M
EPS (Annual)
-$2.99
P/B
1.06
Rev/Employee
$439,432.88
Loading...
Loading...
News
all
press releases
Berenberg Bank Forecasts Strong Price Appreciation for BioNTech (NASDAQ:BNTX) Stock
Berenberg Bank upped their target price on BioNTech from $150.00 to $155.00 and gave the company a "buy" rating in a research report on Thursday...
MarketBeat·9h ago
News Placeholder
More News
News Placeholder
Invesco Ltd. Buys 35,958 Shares of BioNTech SE Sponsored ADR $BNTX
Invesco Ltd. raised its stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 5.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund...
MarketBeat·13h ago
News Placeholder
Temasek Holdings Private Ltd Lowers Holdings in BioNTech SE Sponsored ADR $BNTX
Temasek Holdings Private Ltd lowered its stake in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 16.7% in the second quarter, according to the company in its most recent filing...
MarketBeat·3d ago
News Placeholder
25,780 Shares in BioNTech SE Sponsored ADR $BNTX Bought by Bollard Group LLC
Bollard Group LLC bought a new stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·5d ago
News Placeholder
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Analysts
BioNTech SE Sponsored ADR (NASDAQ:BNTX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the fifteen brokerages that are covering the company, Marketbeat reports. One analyst...
MarketBeat·5d ago
News Placeholder
Dodge & Cox Invests $93.42 Million in BioNTech SE Sponsored ADR $BNTX
Dodge & Cox purchased a new stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The...
MarketBeat·7d ago
News Placeholder
Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules
Shares of vaccine makers slide as an internal FDA memo on vaccine safety and plans for stricter rules spark broad pressure across the overall industry.
Zacks·9d ago
News Placeholder
Groupama Asset Managment Buys 26,681 Shares of BioNTech SE Sponsored ADR $BNTX
Groupama Asset Managment lifted its stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 13.6% in the second quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·12d ago
News Placeholder
Legal & General Group Plc Boosts Stock Position in BioNTech SE Sponsored ADR $BNTX
Legal & General Group Plc raised its position in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 24.6% in the 2nd quarter, according to the company in its most recent disclosure...
MarketBeat·14d ago
News Placeholder
Edmond DE Rothschild Holding S.A. Raises Stock Position in BioNTech SE Sponsored ADR $BNTX
Edmond DE Rothschild Holding S.A. boosted its position in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 12.1% during the 2nd quarter, according to its most recent 13F filing with...
MarketBeat·15d ago

Latest BNTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.